Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers

NARecruitingINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
CancerColorectal NeoplasmsColon, SigmoidMagnetic Resonance ImagingGeneral Surgery
Interventions
OTHER

Preoperative MRI scan

Standard preoperative CT of abdomen, chest and pelvis plus interventional preoperative MRI scan.

Trial Locations (16)

PE29 6NT

RECRUITING

Hinchingbrooke Hospital, Huntingdon

CW1 4QJ

RECRUITING

Leighton Hospital, Crewe

TS19 8PE

RECRUITING

University Hospital of North Tees, Stockton-on-Tees

CR7 7YE

RECRUITING

Croydon University Hospital, Thornton Heath

SS4 5BL

RECRUITING

Chesterfield Royal, Chesterfield

PO6 3LY

RECRUITING

Queen Alexandra Hospital, Portsmouth

HA1 3UJ

RECRUITING

St Mark's Hospital, Middlesex

ME16 9QQ

RECRUITING

Maidstone Hospital, Maidstone

CT9 4AN

RECRUITING

Queen Elizabeth the Queen Mother Hospital, Margate

M8 5RB

RECRUITING

North Manchester General Hospital, Crumpsall

M23 9LT

RECRUITING

University Hospital of South Manchester & Manchester Royal Infirmary, Wythenshawe

HG2 7SX

RECRUITING

Harrogate District Hospital, Harrogate

TA1 5DA

RECRUITING

Musgrove Park Hospital, Taunton

BA21 4AT

ACTIVE_NOT_RECRUITING

Yeovil District Hospital, Yeovil

SM2 5PT

RECRUITING

Royal Marsden Hospital, Sutton

SP2 8BJ

RECRUITING

Salisbury District Hospital, Salisbury

All Listed Sponsors
collaborator

Pelican Cancer Foundation

OTHER

lead

Imperial College London

OTHER

NCT02222844 - Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers | Biotech Hunter | Biotech Hunter